Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
78
-
Total shares
-
22.8M
-
Shares change
-
-8.48M
-
Total reported value, excl. options
-
$108M
-
Value change
-
-$37.5M
-
Put/Call ratio
-
1.65
-
Number of buys
-
38
-
Number of sells
-
-32
-
Price
-
$4.75
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q1 2019
83 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q1 2019.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.8M shares
.
Largest 10 shareholders include BlackRock Inc. (7.55M shares), VANGUARD GROUP INC (4.4M shares), STATE STREET CORP (2.12M shares), NORTHERN TRUST CORP (1.33M shares), GEODE CAPITAL MANAGEMENT, LLC (1.33M shares), Bank of New York Mellon Corp (436K shares), Wildcat Capital Management, LLC (416K shares), Parametric Portfolio Associates LLC (307K shares), BANK OF MONTREAL /CAN/ (291K shares), and DEUTSCHE BANK AG\ (245K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.